In the news | 26th Oct 2022
Embrace a cloud-only approach to streamline your validation
A cloud-only approach or infrastructure provides a vast array of benefits, including, first, offering peace of mind with automated disaster recovery, backups and upgrades; second, ease of use, with simple provisioning of test/sandbox environments as needed, as well as more streamlined deployments; and third, cloud solutions offer flexibility, with systems designed for high availability and resilience.
Read more about this topic in this article by Chris Ovett, Director of Cloud Solutions at IDBS, published in Drug Discovery & Development.
Tradeshow | Festival of Biologics | October 2023
Come and see us at Festival of Biologics in Basel. Visit our booth 604 and hear Marc Smith, Director of Strategic Solutions, speak.
Tradeshow | Biologics Contract Manufacturing Asia | September, 2023
Learn how to overcome manufacturing data challenges with IDBS at this year’s event in Singapore. We look forward to seeing you there!
Digitize pharma lifecycle management for faster regulatory filing
Robust digital workflows in pharma lifecycle management can reduce errors and time to compile data, speeding up regulatory filing.
Is it really an ELN you need?
Thinking of upgrading from a standard ELN? Discover the benefits of centralized BioPharma Lifecycle Management platforms compared to standard ELNs.